Total Payments
$12,991
2024 Payments
$4,007
Companies
84
Transactions
620
Medicare Patients
1,865
Medicare Billing
$428,957
Payment Breakdown by Category
Food & Beverage$12,011 (92.5%)
Education$979.71 (7.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,011 | 606 | 92.5% |
| Education | $979.71 | 14 | 7.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $899.97 | 54 | $0 (2024) |
| Janssen Biotech, Inc. | $803.26 | 27 | $0 (2024) |
| Daiichi Sankyo Inc. | $624.62 | 28 | $0 (2024) |
| Merck Sharp & Dohme LLC | $623.77 | 32 | $0 (2024) |
| PFIZER INC. | $555.06 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $546.58 | 24 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $542.06 | 25 | $0 (2024) |
| Celgene Corporation | $522.42 | 28 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $391.87 | 19 | $0 (2024) |
| Lilly USA, LLC | $353.60 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,007 | 183 | Janssen Biotech, Inc. ($368.68) |
| 2023 | $3,628 | 182 | Merck Sharp & Dohme LLC ($268.68) |
| 2022 | $3,849 | 187 | Novartis Pharmaceuticals Corporation ($282.98) |
| 2021 | $1,231 | 63 | PFIZER INC. ($130.70) |
| 2020 | $99.95 | 1 | Seagen Inc. ($99.95) |
| 2019 | $27.34 | 1 | Amgen Inc. ($27.34) |
| 2018 | $135.23 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($122.01) |
| 2017 | $14.37 | 1 | The Medicines Company ($14.37) |
All Payment Transactions
620 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: HEMATOLOGY | ||||||
| 12/30/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $17.57 | General |
| 12/27/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Oncology | ||||||
| 12/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/17/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $13.30 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 12/16/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Spectrum Pharmaceuticals Inc. | ROLVEDON (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Oncology | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Rare Disease | ||||||
| 11/25/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/25/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.09 | General |
| 11/21/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Coherus Biosciences Inc. | LOQTORZI (Biological), Udenyca | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Hologic Sales and Service, LLC | Localizer (Device), TRIDENT SPECIMEN RADIOGRAPHY SYSTEM | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Breast and Skeletal Health | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 987 | 11,688 | $701,339 | $239,369 |
| 2022 | 16 | 878 | 7,829 | $510,549 | $189,588 |
Total Patients
1,865
Total Services
19,517
Medicare Billing
$428,957
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 28 | 4,522 | $194,265 | $83,245 | 42.9% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 23 | 3,300 | $256,245 | $54,399 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 395 | $88,875 | $36,679 | 41.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 127 | 127 | $37,164 | $19,472 | 52.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 88 | $22,997 | $8,375 | 36.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 57 | $13,110 | $7,599 | 58.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 176 | 883 | $17,660 | $6,693 | 37.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 105 | $15,750 | $6,132 | 38.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 28 | $8,200 | $3,636 | 44.3% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 16 | 157 | $8,850 | $3,332 | 37.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 168 | 437 | $3,059 | $2,985 | 97.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 37 | 63 | $7,026 | $2,966 | 42.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 60 | 277 | $13,850 | $2,825 | 20.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 19 | 84 | $1,680 | $869.40 | 51.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 13 | 1,102 | $12,122 | $108.25 | 0.9% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 12 | 63 | $485.10 | $53.40 | 11.0% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2022 | 15 | 2,600 | $201,890 | $48,550 | 24.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 22 | 2,410 | $103,608 | $41,502 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 254 | $43,029 | $24,588 | 57.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 99 | 99 | $28,970 | $16,157 | 55.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 81 | 261 | $29,553 | $14,321 | 48.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 103 | $22,660 | $14,304 | 63.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 55 | 63 | $18,450 | $9,420 | 51.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 13 | 50 | $13,067 | $5,150 | 39.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 140 | 666 | $13,320 | $5,089 | 38.2% |
About Andre Dixon
Andre Dixon is a Internal Medicine healthcare provider based in Wilson, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2016. The National Provider Identifier (NPI) number assigned to this provider is 1649634486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Andre Dixon has received a total of $12,991 in payments from pharmaceutical and medical device companies, with $4,007 received in 2024. These payments were reported across 620 transactions from 84 companies. The most common payment nature is "Food and Beverage" ($12,011).
As a Medicare-enrolled provider, Dixon has provided services to 1,865 Medicare beneficiaries, totaling 19,517 services with total Medicare billing of $428,957. Data is available for 2 years (2022–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology
- Location Wilson, NC
- Active Since 04/07/2016
- Last Updated 06/30/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649634486
Products in Payments
- KEYTRUDA (Biological) $623.77
- PROVENGE (Drug) $542.06
- Enhertu (Drug) $423.23
- OPDIVO (Biological) $328.03
- Lenvima (Drug) $289.41
- RYBREVANT (Drug) $287.83
- LIBTAYO (Biological) $269.80
- KISQALI (Drug) $251.46
- IMBRUVICA (Drug) $244.12
- REBLOZYL (Biological) $239.66
- LYNPARZA (Drug) $238.79
- ERLEADA (Drug) $235.09
- VERZENIO (Drug) $221.26
- ULTOMIRIS (Biological) $185.90
- Pomalyst (Drug) $182.82
- GILOTRIF (Drug) $171.46
- ZEJULA (Drug) $168.10
- XTANDI (Drug) $162.91
- DARZALEX (Biological) $144.76
- clonoSEQ (Device) $140.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wilson
Charles Baio, Md, MD
Internal Medicine — Payments: $11,365
Internal Medicine $11,365
Richard Burdick, Md, MD
Internal Medicine — Payments: $10,249
Internal Medicine $10,249
Douglas Brewer, Md, MD
Internal Medicine — Payments: $4,551
Internal Medicine $4,551
Medhat Sidaros, Md, MD
Internal Medicine — Payments: $2,846
Internal Medicine $2,846
Jonathon Dewald, M.d, M.D
Internal Medicine — Payments: $2,224
Internal Medicine $2,224
Dr. Jonathan Laird, Md, MD
Internal Medicine — Payments: $1,184
Internal Medicine $1,184